Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and PD-1 in Advanced Colorectal Cancer
NCT06301386Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Apr 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in colorectal cancer (CRC), sponsored by Fudan University. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
everolimus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06301386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301386.